Last reviewed · How we verify
L-pantoprazole sodium
At a glance
| Generic name | L-pantoprazole sodium |
|---|---|
| Sponsor | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Low Dose Bismuth Versus Lactobacillus Reuteri for H. Pylori Eradication (NA)
- A New System for GERD Diagnosis and Treatment
- Eradication of Helicobacter Pylori With a Lactobacillus Reuteri Strain Plus Proton Pump Inhibitor (NA)
- Prophylaxis for Aspiration of Gastric Contents. (PHASE4)
- Efficacy and Safety of L-Pantoprazole Sodium Injection to Treat Upper Gastrointestinal Ulcer Bleeding (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- L-pantoprazole sodium CI brief — competitive landscape report
- L-pantoprazole sodium updates RSS · CI watch RSS
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd. portfolio CI